Utilizing Erythrocyte Lifespan as a Predictor for Moderate to Severe Anemia in Patients with Advanced Gastric Cancer Following Anti-Tumor Treatments: A Prospective Investigation - Top-Institutions - MDSpire

Utilizing Erythrocyte Lifespan as a Predictor for Moderate to Severe Anemia in Patients with Advanced Gastric Cancer Following Anti-Tumor Treatments: A Prospective Investigation

  • By

  • Xiurong Yu

  • Liyu Su

  • Rong Lu

  • Shen Zhao

  • Rongbo Lin

  • Xianren Ye

  • November 19, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Hematology
    • Gastrointestinal Cancer

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Hematology
    • Cancer Biology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Hematology
    • Translational Medicine

  • #4

    National Cancer Center Hospital
    National Cancer Center Hospital

    Tokyo, Tokyo Prefecture

    Key Differentiators

    • Oncology
    • Gastroenterology
    • Hematology

  • #5

    Seoul National University Hospital
    Seoul National University Hospital

    Seoul, Seoul

    Key Differentiators

    • Oncology
    • Hematology
    • Gastroenterology

Original Source(s)

Utilizing Erythrocyte Lifespan as a Predictor for Moderate to Severe Anemia in Patients with Advanced Gastric Cancer Following Anti-Tumor Treatments: A Prospective Investigation

  • by Xiurong Yu, Liyu Su, Rong Lu, Shen Zhao, Rongbo Lin, Xianren Ye

  • November 19, 2025

Related Content

Smoldering Waldenström macroglobulinemia coexisting with myelodysplastic syndrome: a rare case report and literature review

Merging evans syndrome with mucopolysaccharidosis type II: a case report

Prevalence of colorectal cancer and its precursor lesions in symptomatic patients under 55 years of age undergoing total colonoscopy: results of a large retrospective, multicenter, controlled endoscopy study